| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 688228 | Null | 0.012942183459279 | 0.15830039 |
| NSC 693322 | Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- | 0.012942183459279 | 0.04593924 |
| NSC 700862 | 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- | 0.012942183459279 | 0.26181414 |
| NSC 718781 | Erlotinib hydrochloride | 0.012942183459279 | -0.36795358 |
| NSC 720497 | Null | 0.012942183459279 | -0.11045353 |
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.012942183459279 | 0.34086567 |
| NSC 726217 | Combretastatin A4-analogue | 0.012942183459279 | 0.23051138 |
| NSC 726442 | 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride | 0.012942183459279 | 0.25344268 |
| NSC 728078 | 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide | 0.012942183459279 | 0.4169656 |
| NSC 729166 | N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide | 0.012942183459279 | 0.31441869 |